Ziccum AB (publ) (ZICC.ST)

SEK 0.35

(-9.07%)

Long Term Debt Summary of Ziccum AB (publ)

  • Ziccum AB (publ)'s latest annual long term debt in 2023 was 286 Thousand SEK , down -66.63% from previous year.
  • Ziccum AB (publ)'s latest quarterly long term debt in 2024 Q2 was - SEK , down -100.0% from previous quarter.
  • Ziccum AB (publ) reported annual long term debt of 857 Thousand SEK in 2022, down -40.03% from previous year.
  • Ziccum AB (publ) reported annual long term debt of 1.42 Million SEK in 2021, down -28.55% from previous year.
  • Ziccum AB (publ) reported quarterly long term debt of - SEK for 2024 Q3, down 0.0% from previous quarter.
  • Ziccum AB (publ) reported quarterly long term debt of - SEK for 2024 Q2, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Ziccum AB (publ) (2023 - 2017)

Historical Annual Long Term Debt of Ziccum AB (publ) (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 286 Thousand SEK -66.63%
2022 857 Thousand SEK -40.03%
2021 1.42 Million SEK -28.55%
2020 2 Million SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%

Peer Long Term Debt Comparison of Ziccum AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 96.195%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK 86.71%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK 66.353%
Genovis AB (publ.) 74.8 Million SEK 99.618%
Intervacc AB (publ) 142 Thousand SEK -101.408%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 90.467%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 99.122%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 99.562%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 93.343%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK 32.547%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.723%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 71.4%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.97%
Camurus AB (publ) 13.61 Million SEK 97.899%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 98.833%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.966%
Cyxone AB (publ) 74 Thousand SEK -286.486%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 80.084%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 99.105%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -110.294%
SynAct Pharma AB 58 Thousand SEK -393.103%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 66.353%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 83.759%
BioInvent International AB (publ) 14.53 Million SEK 98.032%
Alzinova AB (publ) 800 Thousand SEK 64.25%
Oncopeptides AB (publ) 106.48 Million SEK 99.731%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.685%
Diamyd Medical AB (publ) 30.67 Million SEK 99.068%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.747%
Ascelia Pharma AB (publ) 176 Thousand SEK -62.5%
Diagonal Bio AB (publ) - SEK -Infinity%